Table 2. Survival analysis results of the PCGTs and MESCs Epigenetic Instability Index (EpI) in women's cancers.

	Univariate			Multivariate
PCGT EpI	HR (95%CI)	P	n	HR (95%CI)	P	n
Endo CA	0.80 (0.48–1.33)	0.385	64	0.90 (0.53–1.54)	0.71	63
Ovarian CA	1.34 (1.13–1.59)	7.00E-04	177	1.54 (1.24–1.92)	9.00E-05	161
Cervical CA	0.75 (0.48–1.19)	0.222	48	0.96 (0.59–1.56)	0.878	47
Breast CA	0.99 (0.76–1.29)	0.949	113	0.93 (0.70–1.25)	0.645	107

Univariate and multivariate Cox regression results for the PCGT EpI and MESC EpI (DeMI) in endometrial, ovarian, cervical and breast cancer with number of samples (n), Hazard ratio (HR), 95% confidence interval (CI), and P-value (P). Overall survival was used for endometrial, ovarian and breast cancer, relapse free survival for cervical cancer.